Clinical Trial Update: Biologic Correlative Taxotere/AC [Phase 2]

View source ↗

Summary

Phase 2 trial of Taxotere (docetaxel) plus AC (doxorubicin/cyclophosphamide) for breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)
• Taxotere (docetaxel)

Snippet

Sponsor: Baylor Breast Care Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED